文献速递前列腺增生与排尿功能障碍前列腺癌

Jean Wilson的学术遗产:五十年回顾与展望

Jean Wilson and His Legacy, 50 Years and Counting.
PubMed 文献 · Urology · 2020-12-05

本文回顾1969至2020年医学文献并访谈多位学者,评估内分泌学家Jean Wilson的学术贡献。他于1969年发现5α-还原酶(5AR)并描述双氢睾酮(DHT)为与前列腺生长相关的主要激素,其工作推动了内分泌学、肿瘤学与泌尿外科的协作,促进了前列腺疾病认识与治疗的关键发现。

要点

  • Wilson发现5AR并确立DHT为前列腺生长的主要激素
  • 5AR抑制剂阻断前列腺生长的发现催生了后续临床试验
  • Wilson团队克隆雄激素受体并揭示其作为转录因子的自调控机制

核心结论

  • 基础、转化与临床研究对当前前列腺疾病认识具有关键作用,其中大部分遗产归功于Jean Wilson及其激励的跨领域顶尖科学家交流。

研究设计与样本

  • 综述1969年至2020年医学文献并访谈多位作者。

主要发现

  • 1969年Gloyna与Wilson证明前列腺内睾酮还原为DHT。
  • Wilson与Bruchovsky确立DHT为与前列腺生长相关的主要激素。
  • Wilson进一步表明雄激素参与前列腺发育、生长与功能的各个方面。
  • Wenderoth与Wilson证明5AR抑制剂可阻断前列腺生长,后续由Roehrborn与McConnell领导靶向5AR治疗的临床试验。
  • Tilley与Wilson及Marcelli与McPhaul于1989年在UT Southwestern克隆人类雄激素受体,首次提供雄激素受体作为转录因子可调控自身表达的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the legacy of endocrinologist Jean Wilson, whose discovery in 1969 of 5 alpha-reductase (5AR) and description of dihydrotestosterone (DHT) as the primary hormone associated with prostatic growth ushered in a golden age of collaboration between endocrinologists, oncologists, and urologists that led to some of the critical discoveries in the understanding and treatment of prostatic pathology. MATERIALS AND METHODS: A review of the medical literature between 1969 and 2020 was conducted and multiple authors interviewed. RESULTS: In 1969, Gloyna and Wilson demonstrated the reduction of testosterone to DHT in the prostate. With Bruchovsky, Wilson established that DHT was the primary hormone associated with prostatic growth. Wilson went on to show that androgens are involved in every aspect of prostate development, growth, and function. Wenderoth and Wilson then showed that a 5AR inhibitor blocked the prostatic growth. Subsequently, clinical trials with therapies targeting 5AR were led by Roehrborn and McConnell. Tilley and Wilson with Marcelli and McPhaul cloned the human androgen receptor at UT Southwestern in 1989 and provided the first evidence that androgen receptor was a transcriptional factor that could regulate its own expression in prostate cancer. Androgen receptor mutations explaining the molecular basis of androgen resistance syndromes were first described by Wilson, McPhaul, et al in the early 1990s. CONCLUSION: Basic, translational, and clinical research has played a pivotal role in our current understanding of prostatic disease. Much of this legacy is credited to Jean Wilson and the cross-pollination of world-class scientists across fields, whom he inspired.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Kenigsberg AP, Tilley WD, Raj GV, et al. Jean Wilson and His Legacy, 50 Years and Counting. Urology. 2020. PMID: 33290775. doi:10.1016/j.urology.2020.11.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。